Noor M. Parker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noor M. Parker has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Angela Dramowski
Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
1 shared publication - Eileen du Plooy
University of the Witwatersrand
1 shared publication Francois Retief
Department of Anaesthesiology and Critical Care, Faculty of Medicine and Health Sciences Stellenbosch University and Tygerberg Hospital Cape Town South Africa
1 shared publication- Helena Rabie
Stellenbosch University
1 shared publication - Lisa Frigati
Stellenbosch University
1 shared publication - Marc Merven
Division of Otorhinolaryngology, Department of Surgical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
1 shared publication
Latest Publications
- 14 January 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27478
Airway Management Strategies for Diphtheria‐Induced Severe Upper Airway Obstruction and Pneumonia in Children: Challenges and Solutions in a Low‐Middle Income Settings
- 14 January 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27478
Airway Management Strategies for Diphtheria‐Induced Severe Upper Airway Obstruction and Pneumonia in Children: Challenges and Solutions in a Low‐Middle Income Settings
- Open Access
- 1 January 2025
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 40 (1) , 8
Carbapenem-resistant Enterobacterales colonisation in a tertiary PICU, Cape Town, South Africa
Background: Carbapenem-resistant Enterobacterales (CRE) are important healthcare-associated pathogens in resource-limited paediatric intensive care units (PICUs). The prevalence and clinical predictors of CRE colonisation in South African PICUs are unknown. Objectives: To determine CRE colonisation status in a South African PICU. Method: Between 01 January 2022 and 31 December 2022, we collected admission and exit rectal swabs from children admitted to Tygerberg Hospital PICU, Cape Town. Prevalent CRE was defined as CRE-colonised at PICU admission, including children isolating CRE in the preceding 6 months. Incident CRE was defined as acquisition of CRE colonisation during the PICU stay. Results: Among 638 PICU admissions, we included 552 children (median age 9 months, 54% male) with an entry swab and/or known positive CRE colonisation status; 237 (42.9%) had exit rectal swabs collected. Prevalent CRE was identified in 8% (44/552) on admission, with 29/44 (65.9%) newly identified as CRE-colonised. Incident CRE was identified in 24/227 (10.6%) admissions. Children with prevalent CRE were younger than those not CRE-colonised at PICU entry (median 4.5 months vs 10 months; p < 0.05). Children with incident CRE were younger (median 3 months vs 8 months; p < 0.05), and had longer PICU stays (median 7 vs 4 days; p < 0.05) compared to those who remained CRE-non-colonised. Conclusion: CRE colonisation is common in PICU patients with implications for admission, isolation and antibiotic policies. Better understanding of clinical predictors of CRE colonisation will support the development of appropriate CRE screening recommendations and interventions. Contribution: This study provides insight into the burden and predictors of CRE colonisation in a South African PICU setting.
- 1 January 2025
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 40 (1) , 8
Open AccessCarbapenem-resistant Enterobacterales colonisation in a tertiary PICU, Cape Town, South Africa
Background: Carbapenem-resistant Enterobacterales (CRE) are important healthcare-associated pathogens in resource-limited paediatric intensive care units (PICUs). The prevalence and clinical predictors of CRE colonisation in South African PICUs are unknown. Objectives: To determine CRE colonisation status in a South African PICU. Method: Between 01 January 2022 and 31 December 2022, we collected admission and exit rectal swabs from children admitted to Tygerberg Hospital PICU, Cape Town. Prevalent CRE was defined as CRE-colonised at PICU admission, including children isolating CRE in the preceding 6 months. Incident CRE was defined as acquisition of CRE colonisation during the PICU stay. Results: Among 638 PICU admissions, we included 552 children (median age 9 months, 54% male) with an entry swab and/or known positive CRE colonisation status; 237 (42.9%) had exit rectal swabs collected. Prevalent CRE was identified in 8% (44/552) on admission, with 29/44 (65.9%) newly identified as CRE-colonised. Incident CRE was identified in 24/227 (10.6%) admissions. Children with prevalent CRE were younger than those not CRE-colonised at PICU entry (median 4.5 months vs 10 months; p < 0.05). Children with incident CRE were younger (median 3 months vs 8 months; p < 0.05), and had longer PICU stays (median 7 vs 4 days; p < 0.05) compared to those who remained CRE-non-colonised. Conclusion: CRE colonisation is common in PICU patients with implications for admission, isolation and antibiotic policies. Better understanding of clinical predictors of CRE colonisation will support the development of appropriate CRE screening recommendations and interventions. Contribution: This study provides insight into the burden and predictors of CRE colonisation in a South African PICU setting.